BVX - Bovie Medical Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue38,88336,62729,52027,681
Cost of Revenue19,12218,71216,96318,689
Gross Profit19,76117,91512,5578,992
Operating Expenses
Research Development2,4552,6182,1601,416
Selling General and Administrative21,04719,08917,38313,425
Non Recurring----
Total Operating Expenses42,62440,41936,50633,530
Operating Income or Loss-3,741-3,792-6,986-5,849
Income from Continuing Operations
Total Other Income/Expenses Net-1,477-941,641-7,436
Earnings Before Interest and Taxes-3,741-3,792-6,986-5,849
Interest Expense-136-158-158-151
Income Before Tax-5,218-3,886-5,345-13,285
Income Tax Expense-15664253,997
Minority Interest----
Net Income From Continuing Ops-5,062-3,950-5,370-17,282
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-5,062-3,950-5,370-17,282
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-5,062-3,9508,364-18,214